ArticleOncotarget2018

Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase.

Cheng-Han Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.